Eighteen cases of liver injury following ingestion of Polygonum multiflorum
- PMID: 24559819
- DOI: 10.1016/j.ctim.2013.12.008
Eighteen cases of liver injury following ingestion of Polygonum multiflorum
Abstract
Objectives: Polygonum multiflorum is a popular Chinese herbal medication. In this case series, we report on 18 otherwise healthy non-viral hepatitis patients who developed liver dysfunction following consumption of P. multiflorum alone.
Methods: Concurrent and retrospective analysis was used in this study. The causality of P. multiflorum in liver injury was graded by the Council for International Organizations of Medical Sciences (CIOMS) toxicity scale.
Results: From 2005 to 2012, 18 cases of hepatotoxicity potentially involving P. multiflorum. The median age was 42 years old (range from 18 to 63). Median time of onset of symptoms was 27 days (1-120). Prevailing clinical symptoms were fatigue, loss of appetite and jaundice. Sixteen patients had elevated level of total bilirubin (>21 mol/L); liver enzymes elevated markedly in all patients (ALT>40 U/L, AST>40 U/L, GGT>50 U/L), except for alkaline phosphatase which elevated only in nine patients. Based on the liver enzyme pattern, the type of liver injuries were hepatocellular according to CIOMS. In terms of causality, 14 of 18 patients were evaluated as being highly probable. All patients were responding well to P. multiflorum stoppage, and liver protective-supportive care.
Conclusions: P. multiflorum products can be associated with hepatotoxicity in otherwise healthy non-viral hepatitis infected patients, regardless of herbal processing.
Keywords: Fo-ti; Hepatotoxicity; Polygonum multiflorum.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
[Toxic hepatitis induced by Polygonum multiflorum].Vnitr Lek. 2012 Dec;58(12):958-62. Vnitr Lek. 2012. PMID: 23691566 Slovak.
-
[Comparison of clinical characteristics between patients with Polygonum multiflorum-induced liver injury and those with other drug-induced liver injuries].Zhonghua Gan Zang Bing Za Zhi. 2025 May 20;33(5):463-469. doi: 10.3760/cma.j.cn501113-20250216-00058. Zhonghua Gan Zang Bing Za Zhi. 2025. PMID: 40528591 Chinese.
-
[Clinical Analysis of Drug-induced Liver Injury Caused by Polygonum multiflorum and its Preparations].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Dec;35(12):1442-7. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015. PMID: 26882605 Chinese.
-
Research progress on hepatotoxicity mechanism of polygonum multiflorum and its main components.Toxicon. 2024 Sep;248:108040. doi: 10.1016/j.toxicon.2024.108040. Epub 2024 Jul 20. Toxicon. 2024. PMID: 39038664 Review.
-
The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury.Acta Pharmacol Sin. 2021 Jan;42(1):27-35. doi: 10.1038/s41401-020-0360-3. Epub 2020 Mar 2. Acta Pharmacol Sin. 2021. PMID: 32123300 Free PMC article. Review.
Cited by
-
Polygoni Multiflori Radix interferes with bile acid metabolism homeostasis by inhibiting Fxr transcription, leading to cholestasis.Front Pharmacol. 2023 Mar 6;14:1099935. doi: 10.3389/fphar.2023.1099935. eCollection 2023. Front Pharmacol. 2023. PMID: 36950015 Free PMC article.
-
Screening of Quality Markers During the Processing of Reynoutria multiflora Based on the UHPLC-Q-Exactive Plus Orbitrap MS/MS Metabolomic Method.Front Pharmacol. 2021 Aug 11;12:695560. doi: 10.3389/fphar.2021.695560. eCollection 2021. Front Pharmacol. 2021. PMID: 34456722 Free PMC article.
-
Cis-stilbene glucoside in Polygonum multiflorum induces immunological idiosyncratic hepatotoxicity in LPS-treated rats by suppressing PPAR-γ.Acta Pharmacol Sin. 2017 Oct;38(10):1340-1352. doi: 10.1038/aps.2017.32. Epub 2017 Jun 26. Acta Pharmacol Sin. 2017. PMID: 28649126 Free PMC article.
-
Inhibition of Mitochondrial Complex Function-The Hepatotoxicity Mechanism of Emodin Based on Quantitative Proteomic Analyses.Cells. 2019 Mar 20;8(3):263. doi: 10.3390/cells8030263. Cells. 2019. PMID: 30897821 Free PMC article.
-
Effects of Different Processed Products of Polygonum multiflorum on the Liver.Evid Based Complement Alternat Med. 2020 Mar 9;2020:5235271. doi: 10.1155/2020/5235271. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32215041 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous